Apellis Pharmaceuticals, Inc. (APLS)

20.96 -0.68 (-3.14%) USD  |  NASDAQ  |  Feb 27, 16:00
20.80 -0.16 (-0.76%) After-Hours: 20:00
More

Apellis Pharmaceuticals Stock Based Compensation (Annual)

Stock Based Compensation (Annual) Chart

View Stock Based Compensation (Annual) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual) Range, Past 5 Years

View Stock Based Compensation (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual) Benchmarks

View Stock Based Compensation (Annual) Benchmarks
Start Trial
Ultragenyx Pharmaceutical, Inc. Upgrade
Amneal Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade